![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif)
(IH-tree-um ... eh-doh-TREE-oh-tide)
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of some types of cancer. Yttrium Y 90 edotreotide contains yttrium Y 90 (a radioactive form of the metal yttrium) attached to a molecule that binds to certain types of neuroendocrine tumors (tumors that come from cells that release hormones). The radioactivity from yttrium Y 90 may kill the cancer cells. Also called yttrium Y 90 DOTA-tyr3-octreotide and yttrium Y 90 SMT 487. |
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115192019im_/http://www.cancer.gov/images/spacer.gif) |